CRT Meeting

CRT Meeting CRT 2025 is an interventional cardiology meeting comprised of concurrent meetings in ten areas of interest. Visit CRTmeeting.org for more information.
(1)

CRT is a leading educational forum on new cardiovascular technology and procedures for physicians and health care professionals. Cardiovascular Research Technologies (CRT) is comprised of concurrent meetings in six main areas of interest— Valve & Structural Heart, Coronary, Endovascular, Technology and Innovation, and Nurses & Technologists. CRT provides a forum for exemplary education for interventional cardiologists as well as general cardiologists, cardiothoracic and vascular surgeons, cath lab managers, nurses and technologists, scientists and those with an interest in cardiovascular medicine. Join more than 3,000 interventional and endovascular specialists at CRT 2024 for a comprehensive four-day interventional cardiology conference in Washington, DC from March 9-12. For general inquiries, please email CRTmeeting@gmail.com.

The lipid-lowering therapy evolocumab reduces the risk of adverse cardiovascular events in high-risk patients who have d...
03/29/2026

The lipid-lowering therapy evolocumab reduces the risk of adverse cardiovascular events in high-risk patients who have diabetes but no known significant atherosclerosis, a secondary analysis of the VESALIUS-CV trial shows. Read more from ACC 2026 on CRTonline.

The lipid-lowering therapy evolocumab reduces the risk of adverse cardiovascular events in high-risk patients who have diabetes but no known significant atherosclerosis, a secondary analysis of the VE

Curious about the ACC 2026 late-breaking clinical trials and science? Look no further than CRTonline.org 💜 for all the c...
03/29/2026

Curious about the ACC 2026 late-breaking clinical trials and science? Look no further than CRTonline.org 💜 for all the cardiology and meeting news 🗞️

Catheter-directed fibrinolysis plus anticoagulant medication for the treatment of acute pulmonary embolism has better im...
03/28/2026

Catheter-directed fibrinolysis plus anticoagulant medication for the treatment of acute pulmonary embolism has better immediate clinical outcomes compared with anticoagulants alone, data from the HI-PEITHO trial show. Read more from ACC 2026 on CRTonline.

Catheter-directed fibrinolysis plus anticoagulant medication for the treatment of acute pulmonary embolism (PE) has better immediate clinical outcomes compared with anticoagulants alone, data from the

Left atrial appendage closure (LAAC) is noninferior to blood thinner medications in patients with atrial fibrillation (A...
03/28/2026

Left atrial appendage closure (LAAC) is noninferior to blood thinner medications in patients with atrial fibrillation (AF) who qualify to receive anticoagulant therapy, results from the CHAMPION-AF trial show. Read more from ACC 2026 on CRTonline.

Left atrial appendage closure (LAAC) is noninferior to blood thinner medications in patients with atrial fibrillation (AF) who qualify to receive anticoagulant therapy, results from the CHAMPION-AF tr

Women with premature menopause have a 40% greater lifetime risk for developing coronary heart disease, cardiology resear...
03/28/2026

Women with premature menopause have a 40% greater lifetime risk for developing coronary heart disease, cardiology research shows. Read more on CRTonline.

Women with premature menopause have a 40% greater lifetime risk for developing coronary heart disease (CHD), cardiology research shows.

Improving preventative methods and treatment options for patients with dyslipidemia includes the implication of lifestyl...
03/27/2026

Improving preventative methods and treatment options for patients with dyslipidemia includes the implication of lifestyle changes, medical therapies and proper risk assessment in these patients, new guidelines report from the ACC/AHA. Read more on CRTonline. https://ow.ly/mFKu50YygIT

Treating intermediate-risk pulmonary embolism with large-bore mechanical thrombectomy rather than catheter-directed thro...
03/26/2026

Treating intermediate-risk pulmonary embolism with large-bore mechanical thrombectomy rather than catheter-directed thrombolysis saves nearly $5,000 per patient over a lifetime while delivering comparable or better outcomes, according to a new cost-effectiveness analysis. Read more from CRT 2026 on CRTonline.

Treating intermediate-risk pulmonary embolism (PE) with large-bore mechanical thrombectomy (LBMT) rather than catheter-directed thrombolysis (CDT) saves nearly $5,000 per patient over a lifetime horiz

Radial-to-Peripheral access for peripheral artery intervention is non-inferior in terms of technical success to traditio...
03/26/2026

Radial-to-Peripheral access for peripheral artery intervention is non-inferior in terms of technical success to traditional common femoral artery access and has comparable major adverse limb events, the real-world CARPOOL analysis found. Read more from CRT 2026 on CRTonline.

Radial-to-Peripheral (R2P) access for peripheral artery intervention (PAI) is non-inferior in terms of technical success to traditional common femoral artery (CFA) access and has comparable major adve

03/26/2026

At CRT TV Spring Session 🌷🪻 take a deep dive into the CRT 2026 and ACC 2026 late-breaking clinical trials and science! Featuring drug-coated balloons, renal denervation and more cardiology topics!

➡️ CRTTV.org to register 🪻🌷

Enhanced radiation protection devices reduce scatter radiation exposure for physicians, assistants and nurses in the car...
03/25/2026

Enhanced radiation protection devices reduce scatter radiation exposure for physicians, assistants and nurses in the cardiac catheterization laboratory, compared with standard shielding, a new study shows. Read more from CRT 2026 on CRTonline. https://ow.ly/7E4450Yyg6w

Transfemoral stenting for severe carotid stenosis in addition to intensive medical management halved the risk of stroke ...
03/25/2026

Transfemoral stenting for severe carotid stenosis in addition to intensive medical management halved the risk of stroke and death over 4 years, and reduced post-procedural stroke risk by 75%, the CREST-2 study found. Read more from CRT 2026 on CRTonline. https://ow.ly/WjTi50Yyg0V

Next-generation plaque-sequestrating micronet-covered stents are superior to the first-wave carotid stents proven to red...
03/24/2026

Next-generation plaque-sequestrating micronet-covered stents are superior to the first-wave carotid stents proven to reduce risk of stroke and death in the CREST-2 program, a new analysis of the CGUARDIANS and PARADIGM studies shows, potentially cutting risk of stroke by 30% in these patients. Read more from CRT 2026 on CRTonline.

Next-generation plaque-sequestrating micronet-covered stents (MCS) are superior to the first-wave carotid stents proven to reduce risk of stroke and death in the CREST-2 program, a new analysis of the

Address

Washington D.C., DC

Telephone

+12028777000

Website

Alerts

Be the first to know and let us send you an email when CRT Meeting posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to CRT Meeting:

Shortcuts

Featured

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category

Our Story

CRT is a leading educational forum on new cardiovascular technology and procedures for physicians and health care professionals. Cardiovascular Research Technologies (CRT) is comprised of concurrent meetings in six main areas of interest— Valve & Structural Heart, Coronary, Endovascular, Technology and Innovation, and Nurses & Technologists. CRT provides a forum for exemplary education for interventional cardiologists as well as general cardiologists, cardiothoracic and vascular surgeons, cath lab managers, nurses and technologists, scientists and those with an interest in cardiovascular medicine. Join more than 2,000 interventional and endovascular specialists at CRT 2020 for a comprehensive four-day interventional cardiology conference in National Harbor, MD, from February 22-25, 2020. For general inquiries, please email CRTmeeting@gmail.com.